FNYS
AGN

First New York Securities’s Allergan plc AGN Stock Holding History

First New York Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-200
Closed -$168K – 577
2015
Q1 		$168K Buy
+200
New +$57K 0.17% 70

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

First New York Securities's AGN Position: Q3 2016 in Review

First New York Securities sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 23 shares — an estimated $5.32K sold.

First New York Securities first reported a position in AGN in Q1 2015 and held it in 3 quarters. The position peaked at $2.9M in Q1 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • First New York Securities reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • First New York Securities sold 23 Allergan plc shares in Q3 2016, an estimated $5.32K.
  • First New York Securities first reported a position in Allergan plc in Q1 2015 and held it in 3 quarters.
  • First New York Securities's Allergan plc position peaked at $2.9M in Q1 2016.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on First New York Securities's 13F filing for Q3 2016, filed 18 Oct 2016.